Your browser doesn't support javascript.
loading
Characterization of Patients With Poor-Risk Metastatic Renal-Cell Carcinoma: Results From a Pooled Clinical Trials Database.
Hamieh, Lana; McKay, Rana R; Lin, Xun; Simantov, Ronit; Choueiri, Toni K.
Afiliação
  • Hamieh L; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • McKay RR; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Lin X; Pfizer Oncology, Pfizer Inc, New York, NY.
  • Simantov R; Pfizer Oncology, Pfizer Inc, New York, NY.
  • Choueiri TK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: Toni_Choueiri@dfci.harvard.edu.
Article em En | MEDLINE | ID: mdl-28918175

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article